Bioderived Mesoporous CarbonTungsten Oxide Nanocomposite as a Drug Carrier Vehicle of Doxorubicin for Potent Cancer Therapy
Scientists have investigated the possibility of employing nanomaterials as drug carriers. These nanomaterials can preserve their content and transport it to the target region in the body. In this investigation, we proposed a simple method for developing distinctive, bioderived nanostructures with me...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Langmuir : the ACS journal of surfaces and colloids. - 1992. - 39(2023), 33 vom: 22. Aug., Seite 11910-11924
|
|---|
| 1. Verfasser: |
Bhosale, Sneha R
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Bhosale, Rakhee R,
Patil, Devashree N,
Dhavale, Rushikesh P,
Kolekar, Govind B,
Shimpale, Vinod B,
Anbhule, Prashant V |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2023
|
|---|
| Zugriff auf das übergeordnete Werk: | Langmuir : the ACS journal of surfaces and colloids
|
|---|
| Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Drug Carriers
tungsten oxide
940E10M08M
Carbon
7440-44-0
Doxorubicin
80168379AG |
|---|